RSS   Newsletter   Contact   Advertise with us
Post Online Media

Nouscom appoints John F. McDonald as independent director

Share on Twitter Share on LinkedIn
Staff Writer | Basel, Switzerland | Tuesday November 6, 2018 5:45AM ET
NouscomNouscom, an immuno-oncology company, announced that it has appointed John F. McDonald as an independent director to its board of directors.
Please disable your ad blocker for POST to be able to enjoy our free content.


Mr. McDonald is an accomplished executive leader with more than 25 years' experience in corporate, legal, business development and venture capital in the pharmaceutical and biotech industries.

In this capacity, Mr. McDonald has a depth and breadth of expertise involving academic institutions and biotech and pharmaceutical companies of all stages, including financing, acquisitions, R&D collaborations and in-licensing agreements, among others.

Mr. McDonald currently serves as Corporate VP, Global Business Development at Novo Nordisk, and before this he was VP Business Development at Biogen Inc., Managing Director at the healthcare investment firm MPM Capital, and VP Business Development at Millennium Pharmaceuticals.

 

 LATEST MOVES FROM Switzerland 


POST Online Media Contact

 More inside POST